Chinese EV giant Xpeng (NYSE:XPEV) recently reported its record June and second-quarter deliveries. It continues to be a dominant name in the EV industry, and with several catalysts in place, XPEV stock will continue creating more shareholder value. With incredible year-over-year revenue growth, the stock still trades at a considerable discount to its peers. Source:
0 Comments
Nio (NYSE:NIO) has had one of the most incredible turnarounds in recent memory. The company’s initial public offering (IPO) was priced at $6 per share, and NIO stock stayed in the single digits following the IPO. Source: Sundry Photography / Shutterstock.com While Nio made a decent case about being able to beat Tesla (NASDAQ:TSLA) in
0 Comments
For most securities, determining investment yields is a straightforward exercise. But for debt instruments, this can be more complicated due to the fact that short-term debt markets have various ways of calculating yields and they use different conventions in converting a time period into a year. Here are the four main types of yields: The
0 Comments
The short-squeeze rally in meme stocks like GameStop (NYSE:GME) and AMC Entertainment (NYSE:AMC) is poised to go down in financial history books in terms of shareholder gains. However, a short squeeze is only a temporary phenomenon if the underlying business lacks solid fundamentals. This would be true even for GameStop and AMC if their sky-high
0 Comments
It was almost every kind of modern-day financial swindle rolled into one. The mastermind behind an elaborate stolen credit-card scam that used bitcoin, burner phones and digital wallets such as Apple Pay AAPL, -0.42% to swipe more than $600,000 in luxury goods, has been sentenced to three years in federal prison. (Apple was not immediately
0 Comments
Zevia PBC, a beverage company that makes zero-calorie and zero-sugar beverages with “clean” ingredients, has filed to go public. The Encino, Calif.-based company plans to list class A shares on the New York Stock Exchange under the ticker “ZVIA.” Zevia expects to offer 14.3 million shares at $13 to $15 each. That would value the
0 Comments
Many portfolio managers are increasingly bullish, even with the stock market trading around all-time peaks, according to Citigroup Inc. “Investors want markets to move higher, underscoring the reality that investment professionals are paid to participate and not to sit back and wait for better entry points,” the Citi analysts said in a research note published
0 Comments
Hedge fund founder Anthony Scaramucci told CNBC on Wednesday that the Chinese government’s crackdown on Didi Global, just days after the ride-hailing giant went public in the U.S., is “a direct assault on global capitalism.” “The bad news for the Chinese and the United States now is, if you’re a capital allocator in the United
0 Comments
Investing in clinical-stage biopharmaceutical companies can be hit-or-miss. Other companies are advancing Covid-19 vaccines, of course, but Ocugen (NASDAQ:OCGN) is unique and OCGN stock is still highly affordable. Source: Shutterstock Before taking a position in Ocugen, though, you’ll definitely want to conduct your due diligence. Biotech stocks can move fast — and by that, I mean
0 Comments